This programme provides funding for Aclasta infusions for eligible patients
The infusion is to be provided in the community by the patient’s general practice.
Your Pinnacle Services Contract applies to this service. By claiming for this service, you have indicated that you have read and agreed to the business rules set out here.
This is NOT a clinical guideline.
All Pinnacle practices in Te Whatu Ora Lakes region can claim for this service.
This programme is also funded for patients not enrolled in your practice, who may be referred to you via another service/practice. In these cases, you can only invoice for this service and no other off set can be claimed.
If you are not able to provide any of these procedures for your patients, this care can be provided by another practice in your area. This can be arranged by direct contact between you and the other practice. The practice performing the procedure will invoice Pinnacle directly and there will still be no cost to the patient.
Patients who are Māori, Pacific, a CSC holder or are Quintile 5
Patients domiciled in Te Whatu Ora Lakes area.
Please make your claim via Primary Options, select Aclasta Infusion and then attach the appropriate invoice(s).
Aclasta: $154.50 (including GST)
Please be aware the claim is all inclusive of the GP consult, the administration of the infusion, observation time and consumables.
This service does not include the cost of the medication on special authority, this is the responsibility of the patient to purchase.
The dosing and frequency of administration varies, in accordance with the indication for use. Each administration will require a new claim.
This programme is also funded for patients not enrolled in your practice, who may be referred to you via another service/practice. In these cases, you can only invoice for this service and no other off set can be claimed.
Practices are required to provide sufficiently detailed consultation notes to determine appropriate use of funding.
It has been recommended that in addition to a good assessment and history, the eligibility criteria are clearly stated in the clinical notes.
A patient co-payment cannot be charged.
This service does not include the cost of the medication on special authority, this is the responsibility of the patient to purchase.
The service is funded by Te Whatu Ora.
Primary options team, Pinnacle Midlands Health Network
infoprimaryoptions@pinnacle.health.nz
027 687 7312
People using Accuretic will need to get a new prescription to change to an alternative high blood pressure medicine as soon as possible.
Read moreFrom 1 December 2025, Pharmac will remove Special Authority renewal requirements for several treatments, including insulin pump consumables, continuous glucose monitors, LAMA/LABA inhalers, epoetin alfa, budesonide capsules, and febuxostat.
Read moreNZePS provides a secure messaging channel for prescribing and dispensing systems to exchange prescription information electronically.